Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy

International Braz J Urol

Volumn 37, Issue 5, 2011, Pages 611-616

  Lojanapiwat, B ^a   Tanthanuch, M ^b   Pripathanont, C ^b   Ratchanon, S ^c   Srinualnad, S ^d   Taweemonkongsap, T ^d   Kanyok, S ^d   Lammongkolkul, S ^d  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Calculi; Citrates; Kidney; Lithotripsy; Urolithiasis

Indexed keywords

CITRATE POTASSIUM; CITRATE SODIUM; CITRIC ACID; DIURETIC AGENT; URIC ACID;

ADULT; ARTICLE; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LITHOTRIPSY; MALE; METHODOLOGY; MIDDLE AGED; NEPHROLITHIASIS; PERCUTANEOUS NEPHROSTOMY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; STANDARD; TREATMENT OUTCOME; URINE;

ADULT; CITRATES; DIURETICS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY CALCULI; LITHOTRIPSY; MALE; MIDDLE AGED; NEPHROSTOMY, PERCUTANEOUS; POTASSIUM CITRATE; RECURRENCE; TREATMENT OUTCOME; URIC ACID; YOUNG ADULT;

EID: 84860750533     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382011000500007     Document Type: Article

References (16)

1. El-Nahas AR, El-Assmy AM, Madbouly K, Sheir KZ Predictors of clinical significance of residual fragments after extracorporeal shockwave lithotripsy for renal stones. J Endourol. 2006; 20: 870-4.
2. Soygür T, Akbay A, Küpeli S Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol. 2002; 16: 149-52.
3. Kang DE, Maloney MM, Haleblian GE, Springhart WP, Honeycutt EF, Eisenstein EL, et al. Effect of medical management on recurrent stone formation following percutaneous nephrolithotomy. J Urol. 2007; 177: 1785-8; discussion 1788-9.
4. Mattle D, Hess B Preventive treatment of nephrolithiasis with alkali citrate--a critical review. Urol Res. 2005; 33: 73-9.
5. Trinchieri A, Ostini F, Nespoli R, Rovera F, Montanari E, Zanetti G A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol. 1999; 162: 27-30.
6. Ljunghall S, Danielson BG A prospective study of renal stone recurrences. Br J Urol. 1984; 56: 122-4.
7. Pattaras JG, Moore RG Citrate in the management of urolithiasis. J Endourol. 1999; 13: 687-92.
8. Newman DM, Scott JW, Lingeman JE Two year follow-up of patients treated with extracorporeal shock wave lithotripsy. J Endourol. 1988; 2: 163-71.
9. Ljunghall S Incidence of upper urinary tract stones. Miner Electrolyte Metab. 1987; 13: 220-7.
10. Fine JK, Pak CY, Preminger GM Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy. J Urol. 1995; 153: 27-32; discussion 32-3.
11. Stitchantrakul W, Kochakarn W, Ruangraksa C, Domrongkitchaiporn S Urinary risk factors for recurrent calcium stone formation in Thai stone formers. J Med Assoc Thai. 2007; 90: 688-98.
12. Pak CY: Citrate and renal calculi: an update. Miner Electrolyte Metab. 1994; 20: 371-7.
13. Pak CY Medical management of urinary stone disease. Nephron Clin Pract. 2004; 98: c49-53.
14. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol. 1993; 150: 1761-4.
15. Hofbauer J, Höbarth K, Szabo N, Marberger M Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis--a prospective randomized study. Br J Urol. 1994; 73: 362-5.
16. Ettinger B, Pak CY, Citron JT, Thomas C, Adams--Huet B, Vangessel A Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997; 158: 2069-73.